Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2)

被引:47
|
作者
Janke, Kirsten [1 ]
Brockmeier, Ulf [1 ]
Kuhlmann, Katja [2 ]
Eisenacher, Martin [2 ]
Nolde, Jan [3 ]
Meyer, Helmut E. [2 ]
Mairbaeurl, Heimo [4 ]
Metzen, Eric [1 ]
机构
[1] Univ Duisburg Essen, Fac Med, Inst Physiol, D-45147 Essen, Germany
[2] Ruhr Univ Bochum, Med Proteom Ctr, D-44780 Bochum, Germany
[3] Med Univ Lubeck, Dept Surg, D-23538 Lubeck, Germany
[4] Univ Heidelberg Hosp, Dept Internal Med Sports Med, D-69120 Heidelberg, Germany
关键词
Cell polarity; Hydroxylation; Hypoxia; Protein interaction; ANKYRIN REPEAT DOMAIN; BLOOD-BRAIN-BARRIER; ASPARAGINYL HYDROXYLASE; BETA-HYDROXYLATION; HYPOXIA; ALPHA; NOTCH; PERMEABILITY; HIF-1-ALPHA; STABILITY;
D O I
10.1242/jcs.117564
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The asparaginyl hydroxylase factor inhibiting HIF-1 (FIH-1) is an important suppressor of hypoxia-inducible factor (HIF) activity. In addition to HIF-alpha, FIH-1 was previously shown to hydroxylate other substrates within a highly conserved protein interaction domain, termed the ankyrin repeat domain (ARD). However, to date, the biological role of FIH-1-dependent ARD hydroxylation could not be clarified for any ARD-containing substrate. The apoptosis-stimulating p53-binding protein (ASPP) family members were initially identified as highly conserved regulators of the tumour suppressor p53. In addition, ASPP2 was shown to be important for the regulation of cell polarity through interaction with partitioning defective 3 homolog (Par-3). Using mass spectrometry we identified ASPP2 as a new substrate of FIH-1 but inhibitory ASPP (iASPP) was not hydroxylated. We demonstrated that ASPP2 asparagine 986 (N986) is a single hydroxylation site located within the ARD. ASPP2 protein levels and stability were not affected by depletion or inhibition of FIH-1. However, FIH-1 depletion did lead to impaired binding of Par-3 to ASPP2 while the interaction between ASPP2 and p53, apoptosis and proliferation of the cancer cells were not affected. Depletion of FIH-1 and incubation with the hydroxylase inhibitor dimethyloxalylglycine (DMOG) resulted in relocation of ASPP2 from cell-cell contacts to the cytosol. Our data thus demonstrate that protein interactions of ARD-containing substrates can be modified by FIH-1-dependent hydroxylation. The large cellular pool of ARD-containing proteins suggests that FIH-1 can affect a broad range of cellular functions and signalling pathways under certain conditions, for example, in response to severe hypoxia.
引用
收藏
页码:2629 / 2640
页数:12
相关论文
共 50 条
  • [1] Apoptosis stimulating protein of p53 (ASPP) 1 and ASPP2 m-RNA expression in oral cancer
    Patel, Kinjal D.
    Barasiya, Yesha, V
    Patel, Jayendra B.
    Patel, Prabhudas S.
    ARCHIVES OF ORAL BIOLOGY, 2020, 119
  • [2] Apoptosis Stimulating Protein of p53 2 (ASPP2) expression in acute leukemia modulates response to therapy
    Kampa-Schittenhelm, K.
    Kanz, L.
    Schittenhelm, M.
    ONKOLOGIE, 2011, 34 : 87 - 87
  • [3] Role of the Apoptosis-stimulating protein of p53 2 (ASPP2 or TP53BP2) as a prognostic marker in acute myeloid leukemia
    Kampa-Schittenhelm, K.
    Illing, B.
    Doehner, H.
    Doehner, K.
    Lopez, C.
    Schittenhelm, M. M.
    ONKOLOGIE, 2012, 35 : 116 - 117
  • [4] Differences in hydroxylation and binding of Notch and HIF-1α demonstrate substrate selectivity for factor inhibiting HIF-1 (FIH-1)
    Wilkins, Sarah E.
    Hyvarinen, Jaana
    Chicher, Johana
    Gorman, Jeffrey J.
    Peet, Daniel J.
    Bilton, Rebecca L.
    Koivunen, Peppi
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (07): : 1563 - 1571
  • [5] ASPP2k, an oncogenic splice variant of the Apoptosis-Stimulating Protein of p53-2 (ASPP2) promotes proliferation and invasion in sarcoma
    Tsintari, V
    Walter, B.
    Hinterleitner, C.
    Schittenhelm, M. M.
    Kampa-Schittenhelm, K. M.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 125 - 125
  • [6] Identification of Three Tyrosine Phosphorylation Sites in the p53 Binding Domain of Apoptosis-Stimulating p53 Protein 2 (ASPP2) That Are Differentially Phosphorylated in Response to Chemotherapy in Patient Derived AML Blasts
    Kampa-Schittenhelm, Kerstin M.
    Lopez, Charles D.
    Schittenhelm, Marcus M.
    BLOOD, 2011, 118 (21) : 609 - 610
  • [7] Insights into the role of ASPP2 (Apoptosis stimulating protein of p53-2) in lymphomagenesis
    Kampa-Schittenhelm, K. M.
    Mueller, S.
    Bonin, M.
    Kanz, L.
    Schittenhelm, M. M.
    Lopez, C. D.
    ONKOLOGIE, 2010, 33 : 256 - 256
  • [8] Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene
    Chen, D
    Padiernos, E
    Ding, F
    Lossos, IS
    Lopez, CD
    CELL DEATH AND DIFFERENTIATION, 2005, 12 (04): : 358 - 368
  • [9] Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene
    D Chen
    E Padiernos
    F Ding
    I S Lossos
    C D Lopez
    Cell Death & Differentiation, 2005, 12 : 358 - 368
  • [10] Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax
    Patel, Seema
    George, Roger
    Autore, Flavia
    Fraternali, Franca
    Ladbury, John E.
    Nikolova, Penka V.
    NUCLEIC ACIDS RESEARCH, 2008, 36 (16) : 5139 - 5151